Distalmotion Secures Strategic Investment from Johnson & Johnson to Expand Robotic Surgery in ASCs
The investment follows Distalmotion’s $150M Series G round and supports the growth of DEXTER, a robotic system purpose-built for ambulatory surgery centers.